Hoover Financial Advisors’s AbbVie ABBV Stock Holding History

Hoover Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$233K	Buy	2,071 +488	+31%	+$55K	0.04%	122
2021 Q1	$182K	Buy	1,583 +12	+0.8%	+$1.28K	0.03%	132
2020 Q4	$175K	Buy	+1,571	New	+$151K	0.04%	124
2020 Q3	–	Sell	-1,321	Closed	-$130K	–	187
2020 Q2	$130K	Buy	+1,321	New	+$116K	0.05%	118

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Hoover Financial Advisors's ABBV Position: Q2 2021 in Review

Hoover Financial Advisors increased its AbbVie (ABBV) stake by 31% in Q2 2021, buying an estimated $55K and bringing the position to 2,071 shares worth $233K. The position accounts for 0.04% of the portfolio, ranked #122.

Hoover Financial Advisors first reported a position in ABBV in Q2 2020 and has held it in 4 quarters since. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Hoover Financial Advisors held 2,071 shares of AbbVie worth $233K as of Q2 2021.
Hoover Financial Advisors bought 488 AbbVie shares in Q2 2021, an estimated $55K.
AbbVie made up 0.04% of Hoover Financial Advisors's portfolio in Q2 2021, its #122 holding.
Hoover Financial Advisors first reported a position in AbbVie in Q2 2020 and has held it in 4 quarters since.
2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.